Health Care & Life Sciences » Biotechnology | Array BioPharma Inc.

Array BioPharma Inc. | Balance Sheet

Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
110,998.00
178,326.00
109,942.00
234,323.00
412,487.00
Total Accounts Receivable
5,429.00
6,307.00
39,302.00
31,279.00
32,084.00
Other Current Assets
5,249.00
6,414.00
6,057.00
4,575.00
6,972.00
Total Current Assets
121,676.00
191,047.00
155,301.00
270,177.00
451,543.00
Net Property, Plant & Equipment
8,157.00
5,050.00
6,680.00
8,132.00
7,128.00
Total Investments and Advances
640.00
496.00
596.00
732.00
919.00
Other Assets
8,580.00
1,614.00
6,323.00
104.00
774.00
Total Assets
139,053.00
198,207.00
168,900.00
279,145.00
460,364.00
ST Debt & Current Portion LT Debt
-
-
-
-
18,399.00
Accounts Payable
6,953.00
4,570.00
10,147.00
8,636.00
14,059.00
Other Current Liabilities
45,780.00
37,854.00
42,287.00
60,915.00
63,473.00
Total Current Liabilities
52,733.00
42,424.00
52,434.00
69,551.00
95,931.00
Long-Term Debt
103,952.00
107,280.00
113,655.00
133,905.00
93,376.00
Other Liabilities
8,089.00
5,850.00
40,743.00
63,962.00
51,314.00
Total Liabilities
164,774.00
155,554.00
206,832.00
267,418.00
240,621.00
Common Equity (Total)
25,721.00
42,653.00
37,932.00
11,727.00
219,743.00
Total Shareholders' Equity
25,721.00
42,653.00
37,932.00
11,727.00
219,743.00
Total Equity
25,721.00
42,653.00
37,932.00
11,727.00
219,743.00
Liabilities & Shareholders' Equity
139,053.00
198,207.00
168,900.00
279,145.00
460,364.00

About Array BioPharma

View Profile
Address
3200 Walnut Street
Boulder Colorado 80301
United States
Employees -
Website http://www.arraybiopharma.com
Updated 07/08/2019
Array BioPharma, Inc. engages in the research, development, and commercialization of targeted small molecule drugs for the treatment of cancer and other high-burden diseases. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony Piscopio, K.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.